Clinical Trial Update: TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes completed Phase 1/2 results for the investigational HIV therapies TMB-365 and TMB-380 in suppressed HIV-1-infected individ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TMB-365
• TMB-380

Snippet

Sponsor: TaiMed Biologics Inc. | Conditions: HIV-1-infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-10-22